(Q56978031)

English

Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapies

scientific article published on 01 August 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

0 references

0 references

interstitial lung disease

1 reference

based on heuristic

inferred from title

arterial hypertension

1 reference

based on heuristic

inferred from title

pulmonary hypertension

1 reference

based on heuristic

inferred from title

Jérôme Le Pavec

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Laura K. Hummers

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Gérald Simonneau

9

object named as

Gérald Simonneau

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Stephen C. Mathai

4

object named as

Stephen C Mathai

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Noah Lechtzin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Ari Zaiman

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Reda E Girgis

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Paul M Hassoun

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

1 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Arthritis and Rheumatism

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

63

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

2456-2464

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Changes in causes of death in systemic sclerosis, 1972-2002

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Treatment of pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Systemic sclerosis-associated pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Pulmonary hypertension associated with chronic respiratory disease

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Updated clinical classification of pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Interstitial lung disease in systemic sclerosis: a simple staging system

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Pulmonary veno-occlusive disease

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Is pulmonary arterial hypertension really a late complication of systemic sclerosis?

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Predictors of end stage lung disease in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Clinical differences between idiopathic and scleroderma-related pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Cyclophosphamide versus placebo in scleroderma lung disease.

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Inhaled iloprost for severe pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Systemic sclerosis and bilateral lung transplantation: a single centre experience

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Lung transplantation in patients with scleroderma: case series, review of the literature, and criteria for transplantation

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Identifiers

10.1002/ART.30423

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56978031&oldid=2131051760"